BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 38488852)

  • 1. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor.
    Jablonowski CM; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J
    Elife; 2024 Mar; 12():. PubMed ID: 38488852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor.
    Jablonowski C; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J
    bioRxiv; 2023 Nov; ():. PubMed ID: 37425900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.
    Yi J; Shen HF; Qiu JS; Huang MF; Zhang WJ; Ding JC; Zhu XY; Zhou Y; Fu XD; Liu W
    Nucleic Acids Res; 2017 Apr; 45(6):3503-3518. PubMed ID: 27899633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins.
    Heim A; Grimm C; Müller U; Häußler S; Mackeen MM; Merl J; Hauck SM; Kessler BM; Schofield CJ; Wolf A; Böttger A
    Nucleic Acids Res; 2014 Jul; 42(12):7833-50. PubMed ID: 24914048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
    Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
    Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets.
    Raguz N; Heim A; Engal E; Wesche J; Merl-Pham J; Hauck SM; Erkelenz S; Schaal H; Bensaude O; Wolf A; Salton M; Böttger A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
    Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
    Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.
    Wolf A; Mantri M; Heim A; Müller U; Fichter E; Mackeen MM; Schermelleh L; Dadie G; Leonhardt H; Vénien-Bryan C; Kessler BM; Schofield CJ; Böttger A
    Biochem J; 2013 Aug; 453(3):357-70. PubMed ID: 23688307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
    Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
    Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
    Nijhuis A; Sikka A; Yogev O; Herendi L; Balcells C; Ma Y; Poon E; Eckold C; Valbuena GN; Xu Y; Liu Y; da Costa BM; Gruet M; Wickremesinghe C; Benito A; Kramer H; Montoya A; Carling D; Want EJ; Jamin Y; Chesler L; Keun HC
    Nat Commun; 2022 Mar; 13(1):1380. PubMed ID: 35296644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arginine methylation/demethylation and cancer.
    Poulard C; Corbo L; Le Romancer M
    Oncotarget; 2016 Oct; 7(41):67532-67550. PubMed ID: 27556302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.
    Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ
    J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells.
    Lawrence P; Rieder E
    Virus Genes; 2017 Jun; 53(3):340-351. PubMed ID: 28364140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo.
    Xiao RQ; Ran T; Huang QX; Hu GS; Fan DM; Yi J; Liu W
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200753119. PubMed ID: 35969736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells.
    Eddy AC; Chapman H; Brown DT; George EM
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
    Singh S; Quarni W; Goralski M; Wan S; Jin H; Van de Velde LA; Fang J; Wu Q; Abu-Zaid A; Wang T; Singh R; Craft D; Fan Y; Confer T; Johnson M; Akers WJ; Wang R; Murray PJ; Thomas PG; Nijhawan D; Davidoff AM; Yang J
    Sci Adv; 2021 Nov; 7(47):eabj5405. PubMed ID: 34788094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oxygenase Jmjd6--a case study in conflicting assignments.
    Böttger A; Islam MS; Chowdhury R; Schofield CJ; Wolf A
    Biochem J; 2015 Jun; 468(2):191-202. PubMed ID: 25997831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JMJD6 by 2-Oxoglutarate Mimics.
    Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ
    ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jumonji domain-containing protein 6 protein and its role in cancer.
    Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
    Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.